IMEIK TECHNOLOGY DEVELOPMENT (300896) Stock Price, Fundamentals & Analysis

What 300896 does

IMEIK TECHNOLOGY DEVELOPMENT (300896) is a stock listed on the Shenzhen Stock Exchange in the Healthcare sector, specifically in the Medical Instruments & Supplies industry. The company researches and develops biomedical materials and biopharmaceutical products in China, serving medical aesthetic institutions. Its product portfolio includes cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere, poly facial implant thread, medical sodium hyaluronate-hydroxypropyl methylcellulose gel, sodium hyaluronate composite solution for injection, modified sodium hyaluronate gel for injection, medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose gel, and skin care products. IMEIK TECHNOLOGY DEVELOPMENT was incorporated in 2004 and is headquartered in Beijing, China, with 1,458 employees.

Key numbers explained

• 92,26 CNY is the current price per share, representing the cost to buy one unit of the company on the market.
• The trailing P/E ratio of 25,4 shows how much investors pay per unit of recent earnings; a higher number can suggest higher growth expectations.
• The forward P/E ratio of 19,9 uses expected future earnings, offering a look at valuation based on what analysts anticipate.
• Dividend yield of 1,95% indicates the annual cash return relative to the share price; the exDividendDate is 3 sept. 2026.
• ProfitMargin of 46,2% and operatingMargin of 49,3% reflect how much of each revenue yuan remains as profit after costs and operating expenses.
• Beta of 0,59 suggests the stock has historically moved less than the overall market, often interpreted as lower volatility.
• Debt-to-equity ratio of 0,4 means the company uses less debt than equity to finance its assets, a sign of a relatively conservative capital structure.
• PriceToBook of 3,52 compares the market price to the company's book value per share, showing how the market values its net assets.

What to watch

Investors tracking IMEIK TECHNOLOGY DEVELOPMENT often monitor the medical aesthetic and biomedical materials sector for regulatory and demand shifts. The Shenzhen Stock Exchange listing means the stock is influenced by Chinese market dynamics and policy changes. Comparing IMEIK with peers such as Mindray (300760), Huadong Medicine (000963), Pharmaron Beijing (300759), Zhejiang NHU (002001), Aier Eye Hospital (300015), Yunnan Baiyao Group (000538), and Shanghai RAAS Blood Products (002252) can provide context on sector trends. Broader factors such as currency movements, trade policies, and healthcare spending also affect companies in this space.